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based practice of rounding serum creatinine
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Background: The Cockcroft and Gault equation is widely accepted in practice as the
most appropriate way to calculate an estimated creatinine clearance. Geriatric patients
often present with reduced muscle mass, and therefore lower creatinine production, due
to normal changes in body composition associated with aging. Because serum creatinine
and creatinine clearance are inversely proportional using the Cockcroft and Gault
equation, a lower serum creatinine may falsely overestimate renal function in the elderly
population. Rounding to a normal serum creatinine is believed by some practitioners to
prevent over estimation of creatinine clearance and renal function.
Objective: The objective of this study is to identify and compare medications that require
renal dose adjustment when using the patient's measured serum creatinine, if less than 1
mg/dL, versus a rounded serum creatinine of 1 mg/dL in the Cockcroft and Gault
equation.
Methods: Each patient's estimated creatinine clearance was calculated using the patient's
measured serum creatinine and a rounded value of 1 mg/dl, in the Cockcroft and Gault
equation. Once both creatinine clearances had been calculated, an evaluation was
completed to determine how many of the patient's medications required renal dose
adjustment based on either the measured or rounded creatinine clearance. The number of
dosing discrepancies was then assessed, in addition to creatinine clearance values, to look
for trends or patterns regarding the amount of dosing discrepancies and the effects of
rounding to a serum creatinine of 1 mg/dL.
Results: A total of 32 patients (6 male, 26 female) were evaluated for renal dose
adjustments based on the measured and rounded creatinine clearance. Seven patients
were identified as having discrepancies, all of which were female patients. 'lhe average
difference between the measured and rounded creatinine clearance in female patients was
16 ml.zmin. A total of 12 discrepancies were found affecting 9 different medications.
The average number of discrepancies per patient that presented with a discrepancy was
1.71 discrepancies.
Five of the 12 discrepancies affected both the measured creatinine
clearance and the rounded creatinine clearance, while 7 of the 12 discrepancies affected
only the rounded creatinine clearance.
Conclusion: Results of the study show that patients in CI(D Stage 3. or in CKD Stage 2
but within approximately 16 rnl.zrnin of CKD Stage 3~ are 1110relikely to present with
renal dosing discrepancies, and that the discrepancies identified were not localized to
particular medications or therapeutic areas.
Word Count: 2248
Key Phrases: serum creatinine.

creatine clearance,

elderly,

renal dosing discrepancies
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BACKGROUND
Physiologically,

muscle tissue uses creatine, a nutrient produced primarily

by the

liver and kidneys, as a source of energy. The breakdown of creatine by muscle tissue
results in a waste product called creatinine. Creatinine is then released from muscle
tissue into the blood stream and cleared, almost exclusively,

by the kidneys.

As a result,

creatinine clearance can be used to assess renal function. The Cockcroft and Gault
equation is widely accepted in practice as the most appropriate

way to calculate an

estimated creatinine clearance and is the standard equation used for drug dosage
adjustments.'

This equation accounts for the patient's

and serum creatinine
patient's

age, ideal body weight, gender,

level. Over time, it has been adapted into practice to use the

actual body weight when it is less than the patient's

ideal body weight.

The

following is the Cockcroft and Gault equation:
CrCI (mLimin)

=

[(140 - age) x IBW (x 0.85 for females)] / (SCr x 72).

Normal serum creatinine levels in adults range from 0.6-1.2 mg/dL. Geriatric
patients often present with reduced muscle mass, and therefore lower creatinine
production,

due to normal changes in body composition

serum creatinine

and creatinine

clearance are inversely proportional

and Gault equation, a lower serum creatinine
increased renal function.

associated

with aging.

Because

using the Cockcroft

indicates a higher creatinine clearance and

A normal creatinine clearance ranges from 90 to 130 mLimin.

Questions

have arisen about how to assess renal function in geriatric patients using the

Cockcroft

and Gault equation when low serum creatinine

is due to decreased

muscle

mass and not due to increased renal creatinine clearance.

4
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Accurately
dosing.

estimating renal function in this population

Both over and under dosing medications

of care and patient outcomes.
mass, decreased
creatinine

have consequences

For example, a patient presenting

serum creatinine,

toxicities.

for proper

that impact quality

with decreased

muscle

and decreased renal function may have an estimated

clearance that appears normal via the Cockcroft

dosing of medications

is imperative

and Gault equation.

Over-

in this patient increases the risk for adverse drug effects and

In practice, some clinicians routinely round a serum creatinine

level of less

than 1 mg/dL to 1 mg/dL for use in the Cockcroft and Gault equation in older adults.
Rounding

to a normal serum creatinine is believed by some to more accurately

renal function and prevent over estimation

PREVIOUS

predict

of creatinine clearance and renal function.

STUDIES

Hu et al assessed the relationship

between estimating

creatinine

clearance and

drug dosing errors in the elderly and found that patients with a lower estimated creatinine
clearance

experienced

more dosing errors and that "physicians

renal function in older patients.:"
using measured serum creatinine
decreased measured

This overestimation

routinely overestimate

of renal function is a result of

levels in the Cockcroft and Gault equation when

serum creatinine

is not a result of sufficient renal function, but rather

a result of reduced muscle mass. The practice of rounding to 1 111g/dLhas been adapted
to prevent this overestimation,

although it is not an evidence based method.

However,

there are other studies that assess the practice of rounding the SerU111creatinine to 1
mg/dL and the results have not proven to be better at accurately

assessing renal function.
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Dowling et al found that using a rounded serum creatinine
to a measured
clearance

serum creatinine,

lead to a significantly

lower estimation

when using the Cockcroft and Gault cquation.f

estimates were compared to a patient's
collection,

In addition, when both

underestimated

renal function.

dosing errors.r' This recommendation

further supported by Smythe et al. However, Smythe also addressed

of

is

the degree of the

serum creatinine below 1 mg/dL and the impact on estimating

clearance.

This

that the practice of rounding be avoided due to the underestimation

renal function which leads to sub-therapeutic

measured

of creatinine

actual creatinine clearance via 24 hour urine

the rounded value more significantly

study recommends

of 1 mg/dL, as opposed

creatinine

The study found that "bias was greater and precision less when Ser
of < 0.7 mg/dL were rounded than when Ser concentrations

concentrations

mg/dL were rounded.
concentration

Furthermore,

of> 0.7

"a consistent effect on precision of rounding the SCr

was not evident.,,4

NEED FOR FURTHER STUDY
There is an ongoing need to assess the clinical practice of rounding serum
creatinine

to 1 mg/dL in geriatric patients and its effects on accurately

function.

This non-evidence

There is need to study the prevalence

when assessing patients renal function from calculating

appropriate.

evidence based guidelines

of dosing errors

an estimated creatinine clearance

serum creatinine versus rounded serum creatinine.

need for establishing

Furthermore,

of

C0111mOn

medications

there is a

for when rounding may be considered

Although the objective of this study is not to establish guidelines,

be an evaluation

renal

based practice can lead to dosing errors for medications

requiring renal dose adjustments.

frOITImeasured

estimating

there will

with dose discrepancies.
6
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OBJECTIVE
The objective of the study is to evaluate geriatric patients at a designated
term care facility in Indiana.

For those patients with a serum creatinine

long

less than 1

mg/dL, a review will be completed to assess how many of their current medications
require renal dosage adjustment
creatinine

serum creatinine

rounded to 1 mg/dL in the Cockcroft and Gault equation.

medications

that require dosage adjustment

Common medications
comparing

using their measured

that present discrepancies

in renal dose adjustment

when

measured vs. rounded serum creatinine will be identified.

serum creatinine

as the measured
calculated

The number of

using both methods will be compared.

Here after, the estimated creatinine clearance calculated
measured

versus a SerUlTI

creatinine

value in the Cockcroft

using the patient's

and Gault equation will be referred to

clearance; similarly, the estimated creatinine

clearance

using a rounded serum creatinine value of 1 mg/dl. in the Cockcroft

equation will be referred to as the rounded creatinine

and Gault

clearance.

METHODS
This study is a retrospective
Brownsburg

chart review of geriatric patients residing in the

Health Care Center, a long term care facility in Indiana.

for this study are patients residing in the long term care facility,

Inclusion criteria

patients age 65 and older,

patients with a measured serum creatinine of less than 1 mg/dL, and patients receiving at
least one scheduled medication.

Exclusion criteria for this study are patients on dialysis,

patients with any form of amputation,

patients with a serum creatinine greater than or

equal to 1 mg/dl.., and patients with a height less than or equal to 60 inches.

Only
7
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scheduled

medications

were evaluated.
(including

(including oral medications,

This study excluded all "as needed" medications,

creams, ointments,

and multivitamins.
collection

due to

including: age, gender, height, weight, serum creatinine,

Once all data were collected, each patient's

clearance was calculated

estimated creatinine

using the Cockcroft and Gault equation using both the patient's

serum creatinine and a rounded value of 1 mg/dL.
had been calculated,

medications

topical medications

This study received IRB approval through Butler University

and current medications.

clearances

and patches)

ear/eye drops, enemas, etc.), inhalers and aerosol solutions,

of patient information

measured

injectable medications,

of the patient's

an evaluation

Once both creatinine

was completed to determine how many

current medications

required renal dose adjustment

either the measured or rounded creatinine clearance.

based on

The number of dosing discrepancies

was then assessed, in addition to creatinine clearance values, to look for trends or patterns
regarding

the amount of dosing discrepancies

creatinine

of 1 mg/dL.

and the effects of rounding to a serum

RESULTS
Patient Characteristics
A total of 89 patients were residing in the Brownsburg
time of data collection.
evaluation.

Of that, 32 patients met the study criteria and were subject to

The population

total patients (81.25%).

Health Care Center at the

group was predominately

female with 26 females of the 32

The average age in years and average number of medications

female patients was 78.5 and 9.7 respectively.

Furthermore.

the average difference

between the measured and rounded creatinine clearance was 16

111L)111in

for female

for

Figure 1 details all the patient characteristics

patients.

and the comparisons

between the

male and female patients.

Discrepancies
Of the 32 patients evaluated,

7 patients presented

All 7 patients that presented with discrepancies
patients, a total of 12 discrepancies
discrepancies

per patient.

clearance.

decrease frequency

from 9 various medications.

presented with a variety of renal

including recommendations

to: decrease dose (4/12; 33.3%),

(3/12; 25%), decrease dose and frequency (1/12; 8.3%), and decrease
Furthermore,

was contraindicated

of the n1edications, discrepancies,

3 of the 12 discrepancies

based of the patient's

and dosage recommendations

discrepancies

and creatinine clearance values.

a discrepancy

had a measured creatinine clearance>

then reduce to 30-60 mL/min after calculating

(25%) identified

renal function.

A full list

can be found in Figure 2.

Further analysis was done to identify if there was any relationship

The remaining

clearance,

the discrepancies

dose or frequency (1112; 8.3%).
that the medication

presented

(41.7%) affected both the measured and rounded

Additionally,

dosing recommendations

Among the 7 female

(58.3%) affected only the rounded creatinine

while 5 of the 12 discrepancies
creatinine

were female.

were identified giving an average of 1.71

The 12 discrepancies

Seven of the 12 discrepancies

with renal dosing discrepancies.

between the

Three of the 7 patients that presented wi th
60 mLimin; however, this value was

the patient's

4 patients that presented with discrepancies

clearance of 30-60 111L/min, and the rounded creatinine

rounded creatinine clearance.
had a measured creatinine

clearance remained in that range.

91

A full depiction of the breakdown of patients by creatinine clearance ranges can be seen
in Figure 3.

DISCUSSION
Creatinine Clearance

Values

The creatinine clearance ranges detailed in Figure 3 were identified to give insight
into the Chronic Kidney Disease (CKD) Stage of the patient, whether that patient's CKD
Stage would change after calculating

a rounded creatinine clearance,

and if there was any

relationship between the patients that presented with discrepancies and their CKD Stage.
The CKD Stages, as defined by the KDOQI Clinical Practice Guidelines are as follows:
Stage 1 (normal function; > 90 mUmin),
Stage 3 (moderate
mUmin),

dysfunction;

Stage 2 (mild dysfunction;

30-60 mUmin),

and Stage 5 (failure; < 15 ml.zmin)."

discrepancies

and a measured

Stage 4 (severe dysfunction;

15-30

The 3 patients that presented with

creatinine clearance>

Figure 3) would be categorized

60-89 mUmin),

60 mUmin

into CKD Stage 1 or 2 depending

(as seen in Column 2 of
on the patient's

exact

creatinine clearance value; however, these patient were then re-categorized into CKD
Stage 3 after calculating

a rounded creatinine clearance of 30-60 mUmin.

Keeping in

mind that the average difference between the measured and rounded creatinine clearance
for female patients identified in this study was 16 mUmin,

then patients with a measured

creatinine clearance between approximately 60-76 ml.zrnin

in CKD Stage 2 would be at

the highest risk for being re-categorized
presented with discrepancies

into CKD Stage 3. The remaining 4 patients that

(as seen in Column 3 of Figure 3) met the criteria for CKD

Stage 3 based on both the measured and rounded creatinine clearances.

These findings

give insight to practitioners that patients in CKD Stage 3, or in CKD Stage 2 but within
approximately

16 mL/min of CKD Stage 3, are more likely to present with renal dose

discrepancies.

This helps identify for which patients it may be beneficial

to calculate

both a measured and rounded creatinine clearance using the Cockcroft and Gault equation
and evaluate the risks and benefits of the different renal dosing recommendations.

Clinical implications
A practitioner's

decision to use a measured vs. rounded creatinine

clearance

to determine renal dosing of medications can ultimately affect the patient and the quality
of their care. The following are examples of medications
study as having discrepancies
recommendation.

Keppra (Levetiracetam)

between the prescribed

seizure management;

and the practitioner

was identified as having a discrepancy

recommendation

If that recommendation

risk of inadequate

is to decrease the frequency of

conversely,

if the recommendation

is declined

continues the prescribed dose, the patient may be at an increased risk
side effects."

Similarly, Viread (Tenofovir).

indicated for the treatment of HIV or Hepatitis C, was identified as having a

discrepancy

between the prescribed

practitioner

uses the measured creatinine clearance.

required.

clearances.

is accepted, the patient may be at an increased

of central nervous system and cardiovascular
a medication

of the renal dose adjustment

dosage and both the measured and rounded creatinine

The renal dose adjustment
administration.

and the clinical implications

that were identified in this

However,

dosage and the rounded creatinine

if the practitioner

clearance.

If the

then there is no dose adjustment

uses the rounded creatinine

clearance, the renal
I r that

dose adjustment

recommendation

is to decrease the frequency of administration.

recommendation

is accepted, the patient may be at an increased risk of inadequate
11
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suppression

and disease progression;

the practitioner

conversely,

continues the prescribed

if the recommendation

dose, the patient may be at an increased risk of

central nervous system and endocrine side effects."
of implementing
considered

for patients that present with discrepancies,

recommendations

In summary, the clinical implications

the renal dose adj ustment recommendations

made on a case-by-case

is declined and

must be carefully

and clinical judgement

basis. A full list of the medications,

discrepancies,

must be

and dosage

can be found in Figure 2 and more examples of clinical implications

can be found in Figure 4.

CONCLUSION
In conclusion,

the results of this study show that patients in CKD Stage 3, or in

mL/min of CKD Stage 3, are 1110relikely to

CKD Stage 2 but within approximately

16

present with renal dosing discrepancies,

and that the discrepancies

localized to particular medications

or therapeutic

identified were not

areas.
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FIGURES
Figure 1 - Patient Characteristics
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Figure 2 - Discrepancies

.. .
..

Dosage

-.

...-

R-CrCI Dosage
Recom mendation

Keppra
(Levetiracetam)

500mg po TID

Macrobid
(Nitrofurantoin)

100mg po QHS

Contraindicated

Contrai nd icated

Macrobid
(Nitrofurantoin)

100mg po BID x 10
days

Contraindicated

Contraindicated

Pepcid
(Famotidine)

20mg po BID

N/A

Administer 50% of dose or
increase to q 36-48 hrs

Lyrica
(Pregabalin)

100mg po BID

N/A

50mgpo BID

Zantac
(Ranitidine)

300mg po QHS

150mg po daily

150mg po daily

Zantac
(Ranitidine)

150mg po BID

N/A

150mg po daily

Aldactone
(Spironolactone)

50mg po daily

12.5-25mg po daily

12.5-25mg po daily

Aldactone
(Spironolactone)

50mg po BID

N/A

12.5-25mg po daily

Viread
(Tenofovir)

300mg po daily

N/A

300mg po q 48 hrs

Combivir
(Lamivudinel
Zidovudine)

150/300mg po BID

N/A

Fixed-dose combination
product not recommended

Januvia
(Sitagliptin)

100mg po daily

N/A

50mg po daily

M-CrCI = Measured Creatinine

Clearance;

250-750mg po BID

2S0-750mg po BID

R-CrCI = Rounded Creatinine Clearance
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Figure 3 - Measured

vs. Rounded

Creatinine

Clearance

Ranges

20
18
4

16

14
Females with
Discrepancies
• Females without
Discrepancies

12
10

8

3

Males

6
4
2

3

2

1

M-CrCI > 60

M-CrCI > 60

M-CrCI 30-60

and

and

and

R-CrCI > 60

R-CrCI 30-60

R-CrCI 30-60

o

M-CrCl = Measured Creatinine Clearance;

M-CrCI 30-60
and
R-CrCI < 30

R-CrCl = Rounded Creatinine Clearance
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Figure

4 - Clinical

Implications

Drug

Recommendation

Accept

Decline

Keppra

! Frequency

Risk of inadequate
seizure management

i Risk of eNS and

Macrobid

Contraindicated

NewABX

Untreated UTI

Lyrica

! Dose

Risk of inadequate
pain, seizures, etc.
management

i Risk of eNS

Viread

L Frequency

Risk of inadequate
viral suppression

i Risk of eNS and

Januvia

!Dose

Risk of inadequate
blood glucose control

i Risk of ADRs

CVeffects

effects

endocrine effects
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